Press releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 11, 2019
Vertiflex acquisition adds the only FDA-approved, commercially available, minimally invasive interspinous spacer to Boston Scientific’s chronic pain portfolio.
-
May 22, 2019Findings could expand number of patients who can receive alternative treatment to life-long use of blood thinners
WATCHMAN device findings could expand number of non-valvular atrial fibrillation (AFib) patients who can receive alternative treatment to lifelong use of blood thinners.
-
May 15, 2019
Boston Scientific (BSX) will participate in an upcoming investor conference in May 2019. A live webcast and replay will be available.
-
May 10, 2019New data further support use of S-ICD System as first-line therapy for majority of ICD patients
New clinical trial data further support use of Boston Scientific’s EMBLEM S-ICD System as first-line therapy for majority of ICD patients.
-
May 9, 2019Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies
Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies.